Top Suppliers:I want be here

  • DC Chemicals Limited
  • China
  • Product Name: COR170
  • Price: ¥Inquiry/100mg ¥Inquiry/250mg ¥Inquiry/1g
  • Purity: 98.0%
  • Stocking Period: 10 Day
  • Contact: Tony Cao

1048039-15-1

1048039-15-1 structure
1048039-15-1 structure
  • Name: COR 170
  • Chemical Name: N-(adamant-1-yl)-4-oxo-1-pentyl-6-phenyl-1,4-dihydroquinoline-3-carboxamide
  • CAS Number: 1048039-15-1
  • Molecular Formula: C31H36N2O2
  • Molecular Weight: 468.63000
  • Catalog: Signaling Pathways GPCR/G Protein Cannabinoid Receptor
  • Create Date: 2017-08-12 19:48:46
  • Modify Date: 2024-01-29 09:46:46
  • COR170 (11u) is a selective CB2 inverse-agonist which is a 4-quinolone-3-carboxylic acid derivative with a Ki value of 3.8 nM for CB2 receptor. COR170 can be used for the research of inflammation and neuroprotection[1][2][3].

Name N-(adamant-1-yl)-4-oxo-1-pentyl-6-phenyl-1,4-dihydroquinoline-3-carboxamide
Description COR170 (11u) is a selective CB2 inverse-agonist which is a 4-quinolone-3-carboxylic acid derivative with a Ki value of 3.8 nM for CB2 receptor. COR170 can be used for the research of inflammation and neuroprotection[1][2][3].
Related Catalog
In Vitro COR170 (11u) (0-1 μM) inhibits CB2 receptor in HEK cell membranes[2]. Cell Viability Assay[2] Cell Line: HEK cells Concentration: 0-1 μM Incubation Time: Result: Possessed a Ki value of 3.8 nM for CB2 receptor in HEK cell membranes.
In Vivo COR170 (11u) (1.5-6 mg/kg; i.p, once) reduces the late phase nociceptive behaviour induced by formalin[3]. Animal Model: Mice with formalin (1.25%, 30 μl) injections[3] Dosage: 1.5, 3 and 6 mg/kg Administration: Intraperitoneal injection; 1.5, 3 and 6 mg/kg for once Result: Reduced the late phase nociceptive behaviour induced by formalin with a 6 mg/kg dose and 10 min before formalin and abolished the analgesic effect from GW405833 which is a CB2<>sub receptor partial agonist.
References

[1]. Contartese A, et al. A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury. Pharmacol Res. 2012 Dec;66(6):555-63.

[2]. Pasquini S, et al. Investigations on the 4-quinolone-3-carboxylic acid motif. 2. Synthesis and structure-activity relationship of potent and selective cannabinoid-2 receptor agonists endowed with analgesic activity in vivo. J Med Chem. 2008 Aug 28;51(16):5075-84.

[3]. Cascio MG, et al. In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB(2) receptor inverse agonists. Pharmacol Res. 2010 Apr;61(4):349-54.

Molecular Formula C31H36N2O2
Molecular Weight 468.63000
Exact Mass 468.27800
PSA 51.10000
LogP 6.94820